Found an issue? Give us feedback

Radboud Repositoryarrow_drop_down

Radboud Repository

Article . 2008

Data sources: Radboud Repository

https://pubmed.ncbi.nlm.nih.go...

Article . 2008

Data sources: Europe PubMed Central

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

[Cardiovascular prevention in the over-80 age group is beneficial].

Name: [Cardiovascular prevention in the over-80 age group is beneficial].
Creator: Stalenhoef, A.F.H.
Keywords: Aged, 80 and over, Male, Cost-Benefit Analysis, Health Care Costs, UMCN 2.2: Vascular medicine and diabetes, UMCN 5.1: Genetic defects of metabolism, 3. Good health, Primary Prevention, 03 medical and health sciences, 0302 clinical medicine

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2008 Netherlands Dutch; Flemish Journal:Nederlands tijdschrift voor geneeskunde, volume 152 (issn: 0028-2162,

Authors: Stalenhoef, A.F.H.;

pmid: 18240757

handle: 2066/69330

[Cardiovascular prevention in the over-80 age group is beneficial].

- Summary
- Subjects
- Metrics

Abstract

neHeart failure and stroke are the leading causes ofdisability and hospitalizations in the elderly. Treatment with statins and antihypertensives has been shown to reduce the risk of cardiovascular disease and stroke in trials including elderly persons. Preventive measures are therefore necessary to decrease and compress morbidity, improve quality of life and limit the costs of health care in the elderly. Therefore, old age is no reason in itself to withhold cardiovascular preventive treatment.

Contains fulltext : 69330.pdf (Publisher’s version ) (Closed access)

Country

Netherlands

Related Organizations

Radboud University Nijmegen
Netherlands

Keywords

Aged, 80 and over, Male, Cost-Benefit Analysis, Health Care Costs, UMCN 2.2: Vascular medicine and diabetes, UMCN 5.1: Genetic defects of metabolism, Primary Prevention, Cardiovascular Diseases, Risk Factors, Quality of Life, Humans, Female, NCEBP 14: Cardiovascular diseases, IGMD 5: Health aging / healthy living, Quality of Health Care

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average